The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 34%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (7 analysts) rates it buy, with a mean price target of $47.
KBR, Inc.
KBR · the NYSE · USD · Market cap $4.6B · 36,000 employees
KBR, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-17
Screened 2026-09-17 · the tape above runs as of 23:00 UTC · 21 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 36.70 against the desk's fair-value range, base estimate 56.25, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
KBR, Inc. holds its Markdown at $36.70. Consolidating, no directional conviction, held for 17 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 17 days |
| Price at the screen | $36.70 |
| Valuation | 11.02 trailing · 9.00 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.45 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 43.86% | Below 33% | Interest-bearing debt is 43.9% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 23.30% | Below 49% | Money owed to the company is 23.3% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Conscience OverlayThe quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Fair value range in USD, drawn from the 2026-09-17 screen. The gold marker is the market price at the same screen. A 53.3% margin of safety to the base estimate.
Third-party analyst targets: 7 covering, consensus None. The average target sits +23% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-17 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGovernment work rarely grows when budgets tighten
Governments still need engineering brains for bases, energy projects and defence kit. KBR sits inside that flow, turning specialist know-how into steady contracts across two main divisions. Yet revenue is already shrinking five percent, which undercuts any story of reliable expansion.
The forward multiple sits at just eight point five times, profit margins are thin at five percent, and return on equity looks healthy at twenty nine percent. Our own valuation sits well above the current price, but we still pass. Negative top-line momentum in a cyclical sector usually signals peak earnings rather than a bargain.
Currency swings, contract delays and sudden spending cuts remain real threats even after the ethical screen clears. Analyst targets cluster around forty five dollars, yet the business shows no clear path to sustained growth. Analysis, not advice.
| Forward P/E | 9.0xexpensive even after accounting for its growth |
| Trailing P/E | 11.0xreasonably valued |
| EPS, trailing | 3.32 |
| EPS, forward | 4.06 |
| Revenue growth | +1.6%slow but positive growth |
| Profit margin | 5.5%thin but positive margins |
| Return on equity | 27.5%an exceptional return on shareholder capital |
| FCF yield | 6.10% |
| Dividend yield | 184.00% |
| Debt to equity | 1.70a meaningful debt load worth watching |
| Current ratio | 1.15adequate liquidity, worth monitoring |
| Beta | 0.45barely tracks the market's swings |
| Short interest, float | 0.08% |
| 52-week range | 29.94 - 52.23 |
| Market cap | $4.6B |
| Employees | 36,000 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeKBR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 34%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (7 analysts) rates it buy, with a mean price target of $47.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 34%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (7 analysts) rates it buy, with a mean price target of $47.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 Value Stocks We Find Risky StockStory · 5d ago
- Is Sterling's Semiconductor Push the Next Big Growth Catalyst Today? Zacks · 8d ago
- Should New National Security RF Contract Shape the Spin-Off Path for KBR (KBR) Investors? Simply Wall St. · 8d ago
- Tutor Perini Stock Rises 20% in the Past 3 Months: Time to Buy Yet? Zacks · 11d ago
- KBR Stock In Focus: Defense Tech Unit Wins New US Government Contract Ahead Of Trinzic Spin-Off Stocktwits · 13d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $32.47 | +5.2% | · | $1,052 | +5.2% |
| 2 months | $36.67 | -6.9% | · | $931 | -6.9% |
| 3 months | $36.63 | -6.8% | $0.17 | $937 | -6.3% |
| 6 months | $43.66 | -21.8% | $0.33 | $790 | -21.0% |
| 1 year | $52.02 | -34.4% | $0.66 | $669 | -33.1% |
| 2 years | $62.36 | -45.2% | $1.28 | $568 | -43.2% |
| 3 years | $61.36 | -44.4% | $1.83 | $586 | -41.4% |
| 5 years | $37.91 | -9.9% | $2.78 | $974 | -2.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever KBR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.